SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
111 hedge funds and large institutions have $408M invested in SANGAMO THERAPEUTICS INC in 2013 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 26 reducing their positions, and 9 closing their positions.
1,513% more call options, than puts
Call options by funds: $82.4M | Put options by funds: $5.11M
144% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 9
70% more capital invested
Capital invested by funds: $240M → $408M (+$168M)
54% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 26
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
12% more funds holding
Funds holding: 99 → 111 (+12)
11.56% more ownership
Funds ownership: 43.57% → 55.13% (+12%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$23.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$16.7M |
| 3 |
Jennison Associates
New York
|
+$14.8M |
| 4 |
Goldman Sachs
New York
|
+$10.9M |
| 5 |
PA
Perceptive Advisors
New York
|
+$9.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$11M |
| 2 |
State Street
Boston,
Massachusetts
|
-$5.57M |
| 3 |
KIA
Kopp Investment Advisors
Bloomington,
Minnesota
|
-$2.5M |
| 4 |
Morgan Stanley
New York
|
-$1.95M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.65M |
SGMO Hedge Fund Activity: Q3 2013 in Review
111 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q3 2013, worth a combined $408M — up 70% from $240M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new SGMO positions and 9 closed out — a net gain of 13 holders — while 40 added to existing stakes and 26 trimmed.
The largest buyer was Adage Capital Partners, adding an estimated $23.1M. The largest seller was RA Capital Management, cutting an estimated $11M.
- 111 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q3 2013, up from 99 in Q2 2013.
- Funds reported $408M of SANGAMO THERAPEUTICS INC stock for Q3 2013, up 70% quarter-over-quarter.
- 22 funds opened new SANGAMO THERAPEUTICS INC positions in Q3 2013 and 9 closed out, a net change of +13 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q3 2013 was Adage Capital Partners, an estimated $23.1M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q3 2013 was RA Capital Management, an estimated $11M sold.
Based on aggregated 13F filings for Q3 2013.